Neonatal jaundice laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(8 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
An elevated concentration of [[serum bilirubin]] in neonates in the first 24 hours of life is diagnostic of neonatal jaundice. [[Transcutaneous pacing|Transcutaneous]] [[bilirubin]] level measurement can be diagnostic in cases of mild [[jaundice]]. Other laboratory tests that can be performed include [[blood typing]] and [[Rh disease|Rh]] [[antibodies]] determination, [[liver function tests]], [[direct Coombs test]], [[Serum albumin|serum albumin level]], and [[reticulocyte count]].
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
 
OR
 
[Test] is usually normal among patients with [disease name].
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 
OR
 
There are no diagnostic laboratory findings associated with [disease name].


==Laboratory Findings==
==Laboratory Findings==
*An elevated concentration of [[serum bilirubin]] is diagnostic of neonatal jaundice.
*Laboratory findings consistent with the diagnosis of neonatal jaudice include:<ref name="pmid152319512">{{cite journal| author=American Academy of Pediatrics Subcommittee on Hyperbilirubinemia| title=Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. | journal=Pediatrics | year= 2004 | volume= 114 | issue= 1 | pages= 297-316 | pmid=15231951 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15231951  }}</ref><ref name="pmid9917432">{{cite journal| author=Bhutani VK, Johnson L, Sivieri EM| title=Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. | journal=Pediatrics | year= 1999 | volume= 103 | issue= 1 | pages= 6-14 | pmid=9917432 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9917432  }}</ref>
**Increase of the [[Bilirubin|total bilirubin level]] more than 5 mg/dl.
**Increase of the [[conjugated bilirubin]] level more than 2 mg/dl.


*There are no diagnostic laboratory findings associated with [disease name].
*[[Transcutaneous pacing|Transcutaneous]] [[bilirubin]] level measurment can be diagnostic in cases of mild [[jaundice]].
OR
*Other laboratory tests recommended in cases of neonatal jaundice include the following:<ref name="pmid152319512" />
*An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
** [[Blood type]] and [[Rh disease|Rh]] [[antibodies]] determination in mother and infant
*[Test] is usually normal among patients with [disease name].
** [[Direct Coombs test]]
*Laboratory findings consistent with the diagnosis of [disease name] include:
** [[Hemoglobin]] and [[hematocrit]] values
**[Abnormal test 1]
** Serum [[albumin]] level
**[Abnormal test 2]
** [[Liver function tests]]  
**[Abnormal test 3]
** Peripheral [[blood film]] for [[erythrocyte]] morphology
 
** [[Reticulocyte|Reticulocyte count]]
*Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
** Tests for [[viral]] and/or [[parasitic]] infection


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


​​
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Up-To-Date]]
[[Category:Hematology]]
[[Category:Hepatology]]
[[Category:Pediatrics]]

Latest revision as of 22:57, 29 July 2020

Neonatal jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neonatal jaundice from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neonatal jaundice laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neonatal jaundice laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neonatal jaundice laboratory findings

on Neonatal jaundice laboratory findings

Neonatal jaundice laboratory findings in the news

Blogs on Neonatal jaundice laboratory findings

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

An elevated concentration of serum bilirubin in neonates in the first 24 hours of life is diagnostic of neonatal jaundice. Transcutaneous bilirubin level measurement can be diagnostic in cases of mild jaundice. Other laboratory tests that can be performed include blood typing and Rh antibodies determination, liver function tests, direct Coombs test, serum albumin level, and reticulocyte count.

Laboratory Findings

References

  1. 1.0 1.1 American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation". Pediatrics. 114 (1): 297–316. PMID 15231951.
  2. Bhutani VK, Johnson L, Sivieri EM (1999). "Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns". Pediatrics. 103 (1): 6–14. PMID 9917432.

​​ Template:WH Template:WS